tiprankstipranks
Trending News
More News >
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market

COSMOS Pharmaceutical Corporation (3349) Income Statement

Compare
1 Followers

COSMOS Pharmaceutical Corporation Income Statement

Last quarter (Q4 2025), COSMOS Pharmaceutical Corporation's total revenue was ¥259.12B, an increase of 3.78% from the same quarter last year. In Q4, COSMOS Pharmaceutical Corporation's net income was ¥8.63B. See COSMOS Pharmaceutical Corporation’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.01T¥ 964.99B¥ 827.70B¥ 755.41B¥ 726.42B
Gross Profit
¥ 213.28B¥ 188.31B¥ 168.72B¥ 151.45B¥ 145.11B
Operating Expenses
¥ 172.88B¥ 156.81B¥ 138.59B¥ 121.65B¥ 111.96B
Depreciation and Amortization
¥ 22.23B¥ 19.92B¥ 17.37B¥ 15.11B¥ 13.79B
EBITDA
¥ 64.86B¥ 53.74B¥ 50.19B¥ 48.21B¥ 46.93B
Operating Income
¥ 40.40B¥ 31.50B¥ 30.13B¥ 29.80B¥ 33.15B
Other Income/Expenses
¥ 1.97B¥ 2.22B¥ 2.65B¥ 3.25B¥ 5.45B
Pretax Income
¥ 42.37B¥ 33.72B¥ 32.77B¥ 33.05B¥ 38.60B
Net Income
¥ 30.98B¥ 24.45B¥ 23.80B¥ 23.16B¥ 27.16B
Per Share Metrics
Basic EPS
¥ 390.85¥ 308.61¥ 300.48¥ 292.37¥ 342.89
Diluted EPS
¥ 390.85¥ 308.61¥ 300.48¥ 292.37¥ 342.89
Weighted Average Shares Outstanding
79.26M 79.24M 79.20M 79.20M 79.20M
Weighted Average Shares Outstanding (Diluted)
79.26M 79.24M 79.20M 79.20M 79.20M
Currency in JPY

COSMOS Pharmaceutical Corporation Earnings and Revenue History